The triumphant return of the biotech scorecard

For about a year or so, we would begin every quarter by spelling out the major binary events ahead for biotech and then fill out a scorecard with emojis meant to represent the outcome. This was more work than you might imagine, and it led to weird semiotic debates (does the  emoji signify “taking a bath” or “being showered with riches?”), so we kind of just let it die in silence at the end of 2018.

But the scorecard had more fans than we imagined, and a bunch of them clamored for its return, and we are nothing if not committed to customer service. So it’s back! This time, the emojis are gone but the need-to-know information on the biggest events in biotech remains.

This quarter, that means devilishly important details from Intercept Pharmaceuticals, a milestone approval for Novartis, major data from Myovant Sciences, and more. You can find it all right here, and expect another iteration in three months.